Test Price
2,800 AED✅ Home Collection Available
NLRP7 Gene Hydatidiform Mole Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين NLRP7 للورم الحملي العنقودي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
🔬 Diagnostic Precision
99.9% Diagnostic Sensitivity achieved via ISO 9001:2015 accredited Next Generation Sequencing (NGS) performed in a DHA‑licensed facility (License #9834453).
🚑 Premium Logistics
Paid, hospital‑grade home collection using ISO‑certified cold‑chain transport (8 AM ‑ 11 PM). VIP mobile phlebotomy available.
📞 Clinical Guidance
Post‑test telephonic clinical interpretation session included. Discuss your NLRP7 results with a specialist.
📋 Insurance Verification
Fast Direct Billing check via WhatsApp: +971 54 548 8731
الملخص التنفيذي:
يُعد تحليل جين NLRP7 باستخدام تقنية تسلسل الجينوم الكامل (NGS) فحصًا جينيًا دقيقًا للكشف عن الطفرات المرتبطة بالورم الحملي العنقودي المتكرر. يضمن مختبرنا المعتمد من هيئة الصحة بدبي (DHA) نتائج بدقة تشخيصية تصل إلى 99.9%، مع خدمة سحب العينات المنزلية وفق معايير سلسلة التبريد (Cold Chain) المعتمدة من ISO 9001:2015. نقدم استشارة ما بعد الفحص عبر الهاتف لمساعدتك في تفسير النتائج، ونتحقق من تغطية التأمين مباشرةً عبر واتساب على الرقم +971 54 548 8731.Test Overview & Clinical Superiority
The NLRP7 Gene Hydatidiform Mole Genetic Test detects pathogenic mutations in the NLRP7 gene that cause recurrent complete hydatidiform moles. Our test uses high‑depth NGS with full exon coverage and 2026 DHA‑endorsed variant interpretation.
| Feature | Our NGS Test | Closest Alternative (Sanger Single‑Gene) |
|---|---|---|
| Methodology | NGS – Whole gene sequencing (SNVs, indels, CNVs) | Targeted Sanger sequencing of select exons |
| Sensitivity | >99.9% diagnostic sensitivity | ~95% if limited to common mutations |
| Turnaround Time | 3‑4 Weeks | 4‑6 Weeks |
| Clinical Report | DHA‑compliant, ICD‑10 coded, genetic counselling note | Basic mutation list |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY (DHA: 61713011): “As a clinician, I stress that this NLRP7 test provides vital susceptibility data, but it is not a standalone diagnostic. Results must be interpreted alongside your complete obstetric history, β‑hCG levels, and pelvic imaging. A negative result does not exclude all molar pregnancy risks. Please share this report with your treating gynecologist for integrated care.”
⚠️ Medication & Clinical Notice
Do not discontinue any prescribed medication or supplement, including fertility drugs or anticoagulants, without explicit instruction from your treating physician. Genomic test results should not be used to self‑adjust therapy.
Patient Safety: Exclusion Criteria & Emergency Red Flags
- Exclusion: This blood‑based test should be delayed if you have an active systemic infection, severe coagulopathy, or hematocrit <20%. For FTA card collection, ensure no contamination with amniotic fluid if self‑collecting.
- Red Flag (ER): If you experience sudden severe pelvic pain, heavy vaginal bleeding, passage of grape‑like cysts, or symptoms of hyperthyroidism (tachycardia, tremors, heat intolerance), seek emergency gynecologic evaluation immediately – these may indicate active molar pregnancy complications.
- Pre‑test Requirement: A genetic counselling session to draw a pedigree chart is mandatory before sample collection. This helps identify familial patterns and informs the interpretation of variants of uncertain significance.
Patient FAQ & Clinical Guidance
Q: How does the NLRP7 genetic test differ from a routine molar pregnancy follow‑up?
Answer: This test directly sequences the NLRP7 gene to identify germline mutations that predispose you to recurrent hydatidiform moles, enabling proactive reproductive planning and family‑wide risk assessment beyond standard monitoring.
ج: يقوم هذا التحليل بتسلسل جين NLRP7 مباشرةً لتحديد الطفرات الوراثية التي تزيد من احتمالية تكرار الورم الحملي العنقودي، مما يُمكّن من التخطيط الإنجابي الاستباقي وتقييم المخاطر العائلية بشكل يفوق المتابعة الروتينية.
Q: What sample types are accepted and is there a home collection option in Dubai/Abu Dhabi?
Answer: You can provide whole blood, extracted DNA, or a single drop of blood on an FTA card; our ISO‑certified phlebotomists perform home collection across all UAE emirates between 8 AM and 11 PM.
ج: يمكنك تقديم عينة دم كامل، أو DNA مستخلص، أو قطرة دم واحدة على بطاقة FTA؛ ويقوم أخصائيو سحب الدم المعتمدون لدينا بالزيارة المنزلية في جميع إمارات الدولة بين الساعة 8 صباحاً و11 مساءً.
Q: How will I receive my results and can a doctor explain them to me?
Answer: A secure, encrypted PDF report is issued within 3‑4 weeks, and a post‑test tele‑consultation with a clinical geneticist is included to guide you through the findings and next steps.
ج: يتم إصدار تقرير PDF مشفر وآمن خلال 3-4 أسابيع، وتُتاح لك استشارة هاتفية بعد الفحص مع أخصائي الجينات السريرية لإرشادك خلال النتائج والخطوات التالية.